Table of Contents
INDIA-U.S COLLABORATION
- The Serum Institute of Indiahas collaborated with New York-based CodagenixInc for the purpose of developing a vaccine against the novel coronavirus.
SERUM INSTITUTE OF INDIA
- Serum Institute of India Private Limited operates as a biotechnology company. The Company produces polio, diphtheria, tetanus, pertussis, hib, BCG, r-hepatitis b, measles, mumps, and rubella vaccines.
- Serum Institute of India serves customers worldwide.
- The 53-year-old company makes 1.5 billion doses every year, mainly from its two facilities in the western city of Pune. (It has two other small plants in the Netherlands and the Czech Republic.) Around 7,000 people work for the firm.
- The company supplies some 20 vaccines to 165 countries. Some 80% of its vaccines are exported and, at an average of 50 cents a dose, they are some of the cheapest in the world.
SERUM INSTITUTE OF INDIA
- The company is the world’s largest vaccine producer by number of doses produced.
WHAT SERUM INSTITUTE OF INDIA AND CODAGENIX SAID
WHAT WILL BE THE PRICE?
INDIA’S CHANCE TO SHOW SOFT POWER
- If all goes well India can showcase its medical prowess in front of the world and work on increasing its soft power
- At a time when the world is holding China accountable for coronavirus pandemic, India will emerge as an Asian giant that actually helped the world in this difficult time
Latest Burning Issues | Free PDF
WhatsApp